Type 2 diabetes in octogenarians is associated with decreased low molecular weight adiponectin

Gerontology

Volumn 57, Issue 4, 2011, Pages 316-326

  Graessler, Juergen ^a   Gruber, Matthias ^a   Radke, Rolf Bernd ^b   Kopprasch, Steffi ^a   Schwarz, Peter E H ^a   Kamke, Wolfram ^c   Bornstein, Stefan R ^a   Fischer, Sabine ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Rehabilitation Hospital Wolletzsee   (Germany)

^c Rehabilitation Hospital Spreewaldklinik   (Germany)

Author keywords

Adiponectin; Diabetes mellitus; Octogenarians

Indexed keywords

ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; AGING; ARTICLE; CONTROLLED STUDY; FEMALE; GERIATRIC PATIENT; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MOLECULAR WEIGHT; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPONECTIN; AGE FACTORS; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERIATRIC ASSESSMENT; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; REFERENCE VALUES; RISK ASSESSMENT; SEX FACTORS;

EID: 79959655026     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000316575     Document Type: Article

References (46)

1. Barbieri M, Rizzo MR, Manzella D, Paolisso G: Age-related insulin resistance: is it an obligatory finding? The lesson from healthy centenarians. Diabetes Metab Res Rev 2001; 17: 19-26.
2. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108:1875-1881. (Pubitemid 34015133)
3. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Igura T, Inui Y, Kihara S, Nakamura T, Yamashita S, Miya-gawa J, Funahashi T, Matsuzawa Y: An adi-pocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32:47-50. (Pubitemid 30143606)
4. Tsunekawa T, Hayashi T, Suzuki Y, Matsui-Hirai H, Kano H, Fukatsu A, Nomura N, Miyazaki A, Iguchi A: Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in elderly type 2 diabetic subjects. Diabetes Care 2003; 26: 285-289. (Pubitemid 36929044)
5. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8:1288-1295. (Pubitemid 35373562)
6. Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, Bihain BE, Lodish HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98:2005-2010. (Pubitemid 32165613)
7. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE: Complex distribution, not absolute amount of adiponectin, correlates with thia-zolidinedione-mediated improvement in in-sulin sensitivity. J Biol Chem 2004; 279: 12152-12162. (Pubitemid 38445780)
8. Tsao TS, Murrey HE, Hug C, Lee DH, Lodish HF: Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 k Da (Acrp30). J Biol Chem 2002; 277: 29359-29362. (Pubitemid 41079218)
9. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, vasseur F, Froguel P, Kimura S, Nagai R, Kadowaki T: Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adipo-nectin. J Biol Chem 2003; 278: 40352-40363. (Pubitemid 37248604)
10. Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y: Comparison of serum high-molecular weight (HMW) adiponectin with total adi-ponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin. Diabetes 2006; 55: 1954-1960. (Pubitemid 44509967)
11. Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T, Kadowaki T: A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta 2006; 372: 47-53. (Pubitemid 44286756)
12. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T: Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006; 29:1357-1362. (Pubitemid 44125935)
13. Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y, Funahashi T, Matsuzawa Y: Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94:e27-e31.
14. Seino Y, Hirose H, Saito I, Itoh H: High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men. Metabolism 2007; 56: 1493-1499. (Pubitemid 47562499)
15. Schober F, Neumeier M, Weigert J, Wurm S, Wanninger J, Schaffler A, Dada A, Liebisch G, Schmitz G, Aslanidis C, Buechler C: Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release. Biochem Biophys Res Commun 2007; 361:968-973. (Pubitemid 47259030)
16. Menzaghi C, Salvemini L, Paroni G, De Bonis C, Mangiacotti D, Fini G, Doria A, Di Paola R, Trischitta v: Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondia-betic White Caucasians from Italy: evidence from a family-based study. J Intern Med 2009; 267: 287-294.
17. Neumeier M, Weigert J, Schaffler A, Wehr-wein G, Muller-Ladner U, Scholmerich J, Wrede C, Buechler C: Different effects of ad-iponectin isoforms in human monocytic cells. J Leukoc Biol 2006; 79: 803-808. (Pubitemid 44835612)
18. Coope A, Milanski M, Araujo EP, Tambascia M, Saad MJ, Geloneze B, velloso LA: Adi-poR1 mediates the anorexigenic and insulin/ leptin-like actions of adiponectin in the hy-pothalamus. FEBS Lett 2008; 582:1471-1476.
19. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg AH, Pajvani UB, Scherer PE, Ahima RS: Adiponectin acts in the brain to decrease body weight. Nat Med 2004; 10:524-529. (Pubitemid 38667912)
20. Ebinuma H, Miida T, Yamauchi T, Hada Y, Hara K, Kubota N, Kadowaki T: Improved ELISA for selective measurement of adipo-nectin multimers and identification of adi-ponectin in human cerebrospinal fluid. Clin Chem 2007; 53: 1541-1544. (Pubitemid 47206353)
21. Kusminski CM, McTernan PG, Schraw T, Kos K, O'Hare J P, Ahima R, Kumar S, Scherer PE: Adiponectin complexes in human ce-rebrospinal fluid: distinct complex distribution from serum. Diabetologia 2007; 50: 634-642. (Pubitemid 46215508)
22. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mel-litus and Its Complications. Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeosta-sis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Dia-betologia 1985; 28:412-419. (Pubitemid 15018832)
24. Adamczak M, Rzepka E, Chudek J, Wiecek A: Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005; 62: 114-118. (Pubitemid 40175291)
25. Isobe T, Saitoh S, Takagi S, Takeuchi H, Chiba Y, Katoh N, Shimamoto K: Influence of gender, age and renal function on plasma ad-iponectin level: the Tanno and Sobetsu study. Eur J Endocrinol 2005; 153: 91-98. (Pubitemid 41030520)
26. Combs TP, Berg AH, Rajala MW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, Patti ME, Klein SL, Weinstein RS, Scherer PE: Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003; 52:268-276. (Pubitemid 36173178)
27. Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, Chen B, Lam MC, Tse C, Cooper GJ, Lam KS: Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem 2005; 280: 18073-18080. (Pubitemid 41389052)
28. Leung KC, Xu A, Craig ME, Martin A, Lam KS, O'Sullivan AJ: Adiponectin isoform distribution in women - relationship to female sex steroids and insulin sensitivity. Metabolism 2009; 58: 239-245.
29. Horenburg S, Fischer-Posovszky P, Debatin KM, Wabitsch M: Influence of sex hormones on adiponectin expression in human adipo-cytes. Horm Metab Res 2008; 40: 779-786. (Pubitemid 352772691)
30. Kaser S, Tatarczyk T, Stadlmayr A, Ciardi C, Ress C, Tschoner A, Sandhofer A, Paulweber B, Ebenbichler CF, Patsch JR: Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008; 38:827-834.
31. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N: Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006; 91: 3873-3877. (Pubitemid 44536857)
32. Heidemann C, Sun Q, van Dam RM, Meigs JB, Zhang C, Tworoger SS, Mantzoros CS, Hu FB: Total and high-molecular-weight ad-iponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008; 149:307-316.
33. von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A, Dugi KA: High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 2008; 199: 123-128. (Pubitemid 351842696)
34. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S, Sugiyama T, Miyagishi M, Hara K, Tsunoda M, Murakami K, Ohteki T, Uchida S, Takekawa S, Waki H, Tsuno NH, Shibata Y, Terauchi Y, Froguel P, Tobe K, Koyasu S, Taira K, Kitamura T, Shimizu T, Nagai R, Kadowaki T: Cloning of adiponec-tin receptors that mediate antidiabetic metabolic effects. Nature 2003; 423: 762-769. (Pubitemid 36735700)
35. Altinova AE, Toruner F, Bukan N, Yasar DG, Akturk M, Cakir N, Arslan M: Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J 2007; 54:221-226. (Pubitemid 46798643)
36. Zietz B, Herfarth H, Paul G, Ehling A, Muller-Ladner U, Scholmerich J, Schaffler A: Ad-iponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 2003; 545:103-104. (Pubitemid 36694683)
37. van Hoek M, van Tol A, van vark-van der Zee LC, Jansen H, Kastelein JJ, Sijbrands EJ, Dallinga-Thie GM: Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes. Curr Med Res Opin 2009; 25:93-101.
38. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT: Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55:249-259. (Pubitemid 43343322)
39. Buhl ES, Jessen N, Pold R, Ledet T, Flyvbjerg A, Pedersen SB, Pedersen O, Schmitz O, Lund S: Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 2002; 51: 2199-2206. (Pubitemid 34729025)
40. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B: Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007; 92:571-576.
41. Hara K, Yamauchi T, Imai Y, Manabe I, Nagai R, Kadowaki T: Reduced adiponectin level is associated with severity of coronary artery disease. Int Heart J 2007; 48:149-153. (Pubitemid 46592753)
42. Hashimoto N, Kanda J, Nakamura T, Horie A, Kurosawa H, Hashimoto T, Sato K, Kushida S, Suzuki M, Yano S, Iwai R, Takahashi H, Yoshida S: Association of hypoadiponec-tinemia in men with early onset of coronary heart disease and multiple coronary artery stenoses. Metabolism 2006; 55:1653-1657. (Pubitemid 44827133)
43. Paakko T, Ukkola O, Ikaheimo M, Kesaniemi YA: Plasma adiponectin levels are associated with left ventricular hypertrophy in a random sample of middle-aged subjects. Ann Med 2010; 42:131-137.
44. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CD, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ: Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrinol Metab 2008; 93: 1489-1496. (Pubitemid 351519753)
45. Poehls J, Wassel CL, Harris TB, Havel PJ, Swarbrick MM, Cummings SR, Newman AB, Satterfield S, Kanaya AM: Association of adiponectin with mortality in older adults: the Health, Aging, and Body Composition Study. Diabetologia 2009; 52: 591-595.
46. Wannamethee SG, Whincup PH, Lennon L, Sattar N: Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007; 167: 1510-1517. (Pubitemid 47124181)